妊娠期生理药代动力学模型预测多种酶代谢药物
本研究扩展并验证了妊娠期生理药代动力学模型,通过整合文献中妊娠期酶活性变化数据,预测了经一种或多种细胞色素P450酶代谢的8种药物的药代动力学。该模型可先验识别妊娠期暴露变化,支持临床试验设计决策。
要点
- 妊娠期PBPK模型可定量预测经CYP450酶代谢药物的药代动力学。
- 所有药物预测AUC均在1.25倍误差范围内。
核心结论
- 妊娠期生理药代动力学模型通过整合妊娠对酶影响的先验知识,可定量预测经一种或多种细胞色素P450酶代谢药物的药代动力学。
研究设计与样本
- 研究扩展并验证先前开发的妊娠期生理药代动力学模型,整合文献中妊娠期酶活性变化定量信息,预测8种经一种或多种细胞色素P450酶代谢药物的药代动力学。
- 测试药物为咖啡因、咪达唑仑、硝苯地平、美托洛尔、昂丹司琼、格拉司琼、地西泮和甲硝唑。
- 通过比较文献中体内药代动力学数据评估预测。
主要发现
- 模型成功预测所有测试药物的药代动力学,对妊娠引起的药代动力学变化在定性和定量上预测合理。
- 所有药物的预测AUC均在1.25倍误差范围内。
关键数值与推荐
- 所有药物的预测AUC均在1.25倍误差范围内。
临床怎么用
- 该模型可先验识别妊娠妇女中潜在的药物暴露变化,并最终支持在该特殊人群设计临床试验时的知情决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physiologically based pharmacokinetic modeling is considered a valuable tool for predicting pharmacokinetic changes in pregnancy to subsequently guide in-vivo pharmacokinetic trials in pregnant women. The objective of this study was to extend and verify a previously developed physiologically based pharmacokinetic model for pregnant women for the prediction of pharmacokinetics of drugs metabolized via several cytochrome P450 enzymes. METHODS: Quantitative information on gestation-specific changes in enzyme activity available in the literature was incorporated in a pregnancy physiologically based pharmacokinetic model and the pharmacokinetics of eight drugs metabolized via one or multiple cytochrome P450 enzymes was predicted. The tested drugs were caffeine, midazolam, nifedipine, metoprolol, ondansetron, granisetron, diazepam, and metronidazole. Pharmacokinetic predictions were evaluated by comparison with in-vivo pharmacokinetic data obtained from the literature. RESULTS: The pregnancy physiologically based pharmacokinetic model successfully predicted the pharmacokinetics of all tested drugs. The observed pregnancy-induced pharmacokinetic changes were qualitatively and quantitatively reasonably well predicted for all drugs. Ninety-seven percent of the mean plasma concentrations predicted in pregnant women fell within a twofold error range and 63% within a 1.25-fold error range. For all drugs, the predicted area under the concentration-time curve was within a 1.25-fold error range. CONCLUSION: The presented pregnancy physiologically based pharmacokinetic model can quantitatively predict the pharmacokinetics of drugs that are metabolized via one or multiple cytochrome P450 enzymes by integrating prior knowledge of the pregnancy-related effect on these enzymes. This pregnancy physiologically based pharmacokinetic model may thus be used to identify potential exposure changes in pregnant women a priori and to eventually support informed decision making when clinical trials are designed in this special population.
引用
- Dallmann A, Ince I, Coboeken K, et al. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways. Clin Pharmacokinet. 2018. PMID: 28924743. doi:10.1007/s40262-017-0594-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。